|
Reid, M J; Bornheim, L M (2001) Cannabinoid-induced alterations in brain disposition of drugs of abuse. Biochem Pharmacol 61:1357-67
|
|
Reid, M J; Bornheim, L M (2001) The effects of phencyclidine pretreatment on cocaine-mediated hepatotoxicity in mice. Toxicol Appl Pharmacol 172:194-202
|
|
Bornheim, L M (2000) Effects of unsaturated side-chain analogs of tetrahydrocannabinol on cytochromes P450. Biochem Pharmacol 60:955-61
|
|
Jager, W; Correia, M A; Bornheim, L M et al. (1999) Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: implication for cyclosporine metabolism. Drug Metab Dispos 27:1505-11
|
|
He, K; Bornheim, L M; Falick, A M et al. (1998) Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4. Biochemistry 37:17448-57
|
|
Bornheim, L M (1998) Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity. Toxicol Appl Pharmacol 150:158-65
|
|
Bornheim, L M; Grillo, M P (1998) Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. Chem Res Toxicol 11:1209-16
|
|
Kim, K Y; Bornheim, L M (1997) Determination of esterase-catalyzed cocaine metabolite formation by high-performance liquid chromatography with ultraviolet detection. J Chromatogr Sci 35:287-90
|
|
Jaeger, W; Benet, L Z; Bornheim, L M (1996) Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes. Xenobiotica 26:275-84
|
|
Hampson, A J; Hill, W A; Zan-Phillips, M et al. (1995) Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor. Biochim Biophys Acta 1259:173-9
|
Showing the most recent 10 out of 22 publications
